487 related articles for article (PubMed ID: 29465253)
1. Nanocrystal: a novel approach to overcome skin barriers for improved topical drug delivery.
Patel V; Sharma OP; Mehta T
Expert Opin Drug Deliv; 2018 Apr; 15(4):351-368. PubMed ID: 29465253
[TBL] [Abstract][Full Text] [Related]
2. Nanocrystal for ocular drug delivery: hope or hype.
Sharma OP; Patel V; Mehta T
Drug Deliv Transl Res; 2016 Aug; 6(4):399-413. PubMed ID: 27165145
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical nanocrystals: A promising approach for improved topical drug delivery.
Parmar PK; Wadhawan J; Bansal AK
Drug Discov Today; 2021 Oct; 26(10):2329-2349. PubMed ID: 34265460
[TBL] [Abstract][Full Text] [Related]
4. Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs.
Liu Y; Zhao J; Wang L; Yan B; Gu Y; Chang P; Wang Y
Curr Drug Deliv; 2018; 15(9):1221-1229. PubMed ID: 29779482
[TBL] [Abstract][Full Text] [Related]
5. A Nanocrystals-Based Topical Drug Delivery System with Improved Dermal Penetration and Enhanced Treatment of Skin Diseases.
Sun L; Xiang H; Ge C; Chen X; Zhang Q; Zhang Y; Miao X
J Biomed Nanotechnol; 2021 Dec; 17(12):2319-2337. PubMed ID: 34974856
[TBL] [Abstract][Full Text] [Related]
6. Drug delivery across intact and disrupted skin barrier: Identification of cell populations interacting with penetrated thermoresponsive nanogels.
Rancan F; Giulbudagian M; Jurisch J; Blume-Peytavi U; Calderón M; Vogt A
Eur J Pharm Biopharm; 2017 Jul; 116():4-11. PubMed ID: 27865989
[TBL] [Abstract][Full Text] [Related]
7. Nanocrystal technology in the delivery of poorly soluble drugs: an overview.
Nagarwal RC; Kumar R; Dhanawat M; Das N; Pandit JK
Curr Drug Deliv; 2011 Jul; 8(4):398-406. PubMed ID: 21453258
[TBL] [Abstract][Full Text] [Related]
8. Nanocrystals as an emerging nanocarrier for the management of dermatological diseases.
Parveen N; Abourehab MAS; Thanikachalam PV; Khar RK; Kesharwani P
Colloids Surf B Biointerfaces; 2023 May; 225():113231. PubMed ID: 36907135
[TBL] [Abstract][Full Text] [Related]
9. Topical drug delivery systems: a patent review.
Singh Malik D; Mital N; Kaur G
Expert Opin Ther Pat; 2016; 26(2):213-28. PubMed ID: 26651499
[TBL] [Abstract][Full Text] [Related]
10. Nanocrystal Based Drug Delivery System: Conventional and Current Scenario.
Thakkar S; Shah V; Misra M; Kalia K
Recent Pat Nanotechnol; 2017 Jul; 11(2):130-145. PubMed ID: 27758683
[TBL] [Abstract][Full Text] [Related]
11. Production of nanosuspensions as a tool to improve drug bioavailability: focus on topical delivery.
Lai F; Schlich M; Pireddu R; Corrias F; Fadda AM; Sinico C
Curr Pharm Des; 2015; 21(42):6089-103. PubMed ID: 26503149
[TBL] [Abstract][Full Text] [Related]
12. Broad overview of engineering of functional nanosystems for skin delivery.
Mota AH; Rijo P; Molpeceres J; Reis CP
Int J Pharm; 2017 Nov; 532(2):710-728. PubMed ID: 28764984
[TBL] [Abstract][Full Text] [Related]
13. Nanocrystals for improved dermal drug delivery.
Pelikh O; Stahr PL; Huang J; Gerst M; Scholz P; Dietrich H; Geisel N; Keck CM
Eur J Pharm Biopharm; 2018 Jul; 128():170-178. PubMed ID: 29680482
[TBL] [Abstract][Full Text] [Related]
14. Delivery and targeting of nanoparticles into hair follicles.
Fang CL; Aljuffali IA; Li YC; Fang JY
Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
[TBL] [Abstract][Full Text] [Related]
15. Nanocarrier-based topical drug delivery for the treatment of skin diseases.
Gupta M; Agrawal U; Vyas SP
Expert Opin Drug Deliv; 2012 Jul; 9(7):783-804. PubMed ID: 22559240
[TBL] [Abstract][Full Text] [Related]
16. Nanocrystals for Improving Oral Bioavailability of Drugs: Intestinal Transport Mechanisms and Influencing Factors.
Tian Z; Mai Y; Meng T; Ma S; Gou G; Yang J
AAPS PharmSciTech; 2021 Jun; 22(5):179. PubMed ID: 34128132
[TBL] [Abstract][Full Text] [Related]
17. Topically applied lipid- and surfactant-based nanoparticles in the treatment of skin disorders.
Desmet E; Van Gele M; Lambert J
Expert Opin Drug Deliv; 2017 Jan; 14(1):109-122. PubMed ID: 27348356
[TBL] [Abstract][Full Text] [Related]
18. Formulation design for topical drug and nanoparticle treatment of skin disease.
Raphael AP; Garrastazu G; Sonvico F; Prow TW
Ther Deliv; 2015 Feb; 6(2):197-216. PubMed ID: 25690087
[TBL] [Abstract][Full Text] [Related]
19. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
[TBL] [Abstract][Full Text] [Related]
20. Progress in Topical siRNA Delivery Approaches for Skin Disorders.
Aldawsari M; Chougule MB; Babu RJ
Curr Pharm Des; 2015; 21(31):4594-605. PubMed ID: 26362644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
